Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder.

Neuroscience letters - 20 Feb 2006

Nishiguchi Naoki, Breen Gerome, Russ Carsten, St Clair David, Collier David

Abstract excerpt

Glycogen synthase kinase-3beta (GSK3beta) is a target of lithium as well as sodium valproate, both of which are effective mood stabilizing prophylatics/treatments for bipolar disorder, a highly heritable psychiatric disorder. Though it is not clear whether the mood stabilizing effects of these drugs act directly through GSK3beta, it is a good candidate for mediating at least part of lithium's action, and is an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder
Share to Chromosome Mapping
Share to Gene Frequency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycogen Synthase Kinase 3

Share to Glycogen Synthase Kinase 3 beta

Share to Psychiatric Status Rating Scales

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to United Kingdom

Source

Identifiers

PMID: 16289783
DOI: 10.1016/j.neulet.2005.10.042

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder.PMID 16289783Read ↗

Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.Semantic proximity Read ↗

Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.Semantic proximity Read ↗

The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies.Semantic proximity Read ↗

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.Semantic proximity Read ↗

Increase in GSK3beta gene copy number variation in bipolar disorder.Semantic proximity Read ↗

No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.Semantic proximity Read ↗

Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.Semantic proximity Read ↗

[Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].Semantic proximity Read ↗

No significant association between the genetic polymorphisms in the GSK-3 beta gene and schizophrenia in the Chinese population.Semantic proximity Read ↗

Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.Semantic proximity Read ↗

The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.Semantic proximity Read ↗

No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.